Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology.

Four serum neurofilament light chain tests show high accuracy in diagnosing ALS and predicting its progression, new research suggests.

Amyotrophic lateral sclerosis could soon be diagnosed from a muscle biopsy thanks to a possible diagnostic biomarker that’s been identified in muscle tissue. Amyotrophic lateral sclerosis (ALS) is a ...

Proposed McDonald criteria revisions could help diagnose MS patients who would have been missed with earlier versions, an analysis shows.

WEST PALM BEACH, Fla. — New research testing the newly proposed McDonald Criteria showed that 32% more patients with a ...

Revisions made in 2024 to the McDonald criteria allowed for the diagnosis of multiple sclerosis in a small cohort of ...

The absence of a formal ALS diagnosis can ... hinder the planning and medical management of PMA When a patient presents to the clinic with weakness, a frequent concern is whether the symptoms ...

For the early detection of Alzheimer's disease, so-called p-tau proteins in the blood are not as disease-specific as ...

as defined by El Escorial Revised ALS diagnostic criteria, using fasudil or its active metabolite. Further claims are directed to reducing neurofilament light (NfL). Woolsey also has Orphan Drug ...